Cover Image
市場調查報告書

唾液腺癌:全球臨床實驗趨勢

Salivary Gland Cancer Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 167102
出版日期 內容資訊 英文 83 Pages
訂單完成後即時交付
價格
Back to Top
唾液腺癌:全球臨床實驗趨勢 Salivary Gland Cancer Global Clinical Trials Review, H1, 2015
出版日期: 2015年03月27日 內容資訊: 英文 83 Pages
簡介

本報告提供全球唾液腺癌治療藥臨床實驗相關調查,提供您各地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗等資料。

簡介

  • 唾液腺癌
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:腫瘤治療藥臨床實驗上唾液腺癌的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腫瘤治療藥臨床實驗上唾液腺癌的比例

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

唾液腺癌治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • AstraZeneca PLC
    • Bristol-Myers Squibb Company
    • 大塚集團
    • Biotec Pharmacon ASA
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Fox Chase Cancer Center
    • University Health Network
    • University of Washington
    • Eastern Cooperative Oncology Group
    • University of Chicago
    • University of Texas M. D. Anderson Cancer Center
    • Ontario Clinical Oncology Group
    • Stanford University

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2606CTIDB

GlobalData's clinical trial report, "Salivary Gland Cancer Global Clinical Trials Review, H1, 2015" provides data on the Salivary Gland Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Salivary Gland Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Salivary Gland Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Salivary Gland Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Salivary Gland Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Salivary Gland Cancer to Oncology Clinical Trials
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Salivary Gland Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Salivary Gland Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Otsuka Holdings Co., Ltd.
      • Clinical Trial Overview of Otsuka Holdings Co., Ltd.
      • Biotec Pharmacon ASA
      • Clinical Trial Overview of Biotec Pharmacon ASA
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Fox Chase Cancer Center
      • Clinical Trial Overview of Fox Chase Cancer Center
      • University Health Network
      • Clinical Trial Overview of University Health Network
      • University of Washington
      • Clinical Trial Overview of University of Washington
      • Eastern Cooperative Oncology Group
      • Clinical Trial Overview of Eastern Cooperative Oncology Group
      • University of Chicago
      • Clinical Trial Overview of University of Chicago
      • University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center
      • Ontario Clinical Oncology Group
      • Clinical Trial Overview of Ontario Clinical Oncology Group
      • Stanford University
      • Clinical Trial Overview of Stanford University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Salivary Gland Cancer Therapeutics, Global, Clinical Trials by Region, 2015*
  • Salivary Gland Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Salivary Gland Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Salivary Gland Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Salivary Gland Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Salivary Gland Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Salivary Gland Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Salivary Gland Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Salivary Gland Cancer Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Salivary Gland Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Salivary Gland Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Salivary Gland Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Salivary Gland Cancer Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Salivary Gland Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotec Pharmacon ASA, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ontario Clinical Oncology Group, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2015*

List of Figures

  • Salivary Gland Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Salivary Gland Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Salivary Gland Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proportion of Salivary Gland Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Salivary Gland Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Salivary Gland Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Salivary Gland Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Salivary Gland Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Salivary Gland Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Salivary Gland Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Salivary Gland Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Salivary Gland Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Salivary Gland Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top